Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis c patients: A case control study

Frank C. Bekkering, Avidan U. Neumann, Johannes T. Brouwer, Rachel S. Levi-Drummer, Solko W. Schalm

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

Background: High dose interferon induction treatment of hepatitis C viral infection blocks viral production over 95%. Since dose reduction is often performed due to clinical considerations, the effect of dose reduction on hepatitis C virus kinetics was studied. Methods: A new model that allowed longitudinal changes in the parameters of viral dynamics was used in a group of genotype-1 patients (N = 15) with dose reduction from 10 to 3 million units of interferon daily in combination with ribavirin, in comparison to a control group (N = 9) with no dose reduction. Results: Dose reduction gave rise to a complex viral kinetic pattern, which could be only explained by a decrease in interferon effectiveness in blocking virion production. The benefit of the rapid initial viral decline following the high induction dose is lost after dose reduction. In addition, in some patients also the second phase viral decline slope, which is highly predictive of success of treatment, was impaired by the dose reduction resulting in smaller percentage of viral clearance in the dose reduction group. Conclusions: These findings, while explaining the failure of many induction schedules, suggest that for genotype-1 patients induction therapy should be continued till HCVRNA negativity in serum in order to increase the sustained response rate for chronic hepatitis C.

Original languageEnglish
Article number14
JournalBMC Gastroenterology
Volume1
DOIs
StatePublished - 13 Dec 2001

Fingerprint

Dive into the research topics of 'Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis c patients: A case control study'. Together they form a unique fingerprint.

Cite this